about
Desferrithiocin analogue uranium decorporation agents.Advances in iron chelation: an update.The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients.Agranulocytosis due to deferiprone: a case report with cytomorphological and functional bone marrow examinationDesferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicitySubstituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.(S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicityRemoval of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemiaDesign, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues.Desferrithiocin analogues and nephrotoxicity.Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone.Frequency of neutropenia among Turkish and Syrian pediatric thalassemia patients under deferiprone monotherapy.The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients.The effect of combined therapy with deferoxamine and deferiprone on serum ferritin level of beta-thalassemic patients.
P2860
Q33818209-A92F8F09-75DA-4860-A1E2-1ED63E87D688Q34174307-10C6EE0F-1024-46F5-93EE-FE1AD832B2DBQ34181082-BE4F8E94-D179-425D-8B8D-145BBCA4BC9BQ34316787-562E5C43-CEC2-421D-9C83-9C3A93F8FDC2Q35434460-88F77243-B6AF-48F1-BC90-C9E7EEC0218FQ35896606-82403265-CB99-4A93-9B9E-391BD102D350Q36642048-7312C209-15AC-437C-BFA6-02C0BC49D047Q36857692-15041DF5-E79E-4694-AF6A-FD9320215DFEQ36899188-165F8877-AB46-481F-BEDE-CB82273AA586Q37372510-00AB7D61-AC70-4043-AC41-B90876635EF0Q37381807-69AC7540-C8FD-4608-9246-41DD5D0C3557Q37423512-DD72DE90-9CF5-49B6-B0A4-B22AFD77A92BQ37762809-8C46AB38-89A2-4250-9204-168F81914A85Q40776444-CFB732E5-5604-45DE-A887-724620DF43A3Q44051897-6EAE6F79-D6AE-4B93-9681-BF4D2A188014Q45817965-4E7E6ABC-785E-47E0-9114-2B056C7CF30F
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Long-term therapy with deferiprone.
@en
type
label
Long-term therapy with deferiprone.
@en
prefLabel
Long-term therapy with deferiprone.
@en
P356
P1433
P1476
Long-term therapy with deferiprone.
@en
P2093
N F Olivieri
P356
10.1159/000203854
P577
1996-01-01T00:00:00Z